In addition, vascular endothelial growth factor inhibitors and tumor-treating fields have also been approved for the treatment of glioblastoma (Lassman et al., 2020; Seystahl et al., 2020; Zhang et al., 2020). Here, VEGFA is linked to glioblastoma.